Showing results (71-80 of 681) with videos related to
Sort By:
Pageof 69
Methods in Molecular Biology (Clifton, N.J.)|April 15, 2016
Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment VirusesMichael A Whitt, Thomas W Geisbert, Chad E MireExpert Opinion on Drug Discovery|October 2, 2018
Small animal models of filovirus disease: recent advances and future directionsRobert W Cross, Karla A Fenton, Thomas W GeisbertMethods in Molecular Biology (Clifton, N.J.)|August 23, 2023
Overview of Experimental Vaccines and Antiviral Therapeutics for Henipavirus InfectionBenjamin A Satterfield, Chad E Mire, Thomas W GeisbertEmerging Infectious Diseases|April 13, 2016
Effective Chemical Inactivation of Ebola VirusElaine Haddock, Friederike Feldmann, Heinz FeldmannThe Journal of Infectious Diseases|May 8, 2015
Natural Immunity to Ebola Virus in the Syrian Hamster Requires Antibody ResponsesJoseph Prescott, Darryl Falzarano, Heinz FeldmannThe Journal of Infectious Diseases|June 8, 2018
Ebola Virus Infection in Commonly Used Laboratory Mouse StrainsElaine Haddock, Heinz Feldmann, Andrea MarziScience Translational Medicine|August 10, 2012
A Hendra virus G glycoprotein subunit vaccine protects African green monkeys from Nipah virus challengeKatharine N Bossart, Barry Rockx, Friederike Feldmann, et al.Journal of Virology|July 28, 2010
A novel model of lethal Hendra virus infection in African green monkeys and the effectiveness of ribavirin treatmentBarry Rockx, Katharine N Bossart, Friederike Feldmann, et al.Nature Communications|July 29, 2020
Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatmentRobert W Cross, Zachary A Bornholdt, Abhishek N Prasad, et al.Methods in Molecular Biology (Clifton, N.J.)|June 3, 2017
Ebolavirus: An Overview of Molecular and Clinical PathogenesisVeronica Vine, Dana P Scott, Heinz FeldmannPageof 69